A fund with sector focus
Rhenman Healthcare Equity L/S is a hedge fund with its full focus on the healthcare sector. Our expertise and our unique working method, where the portfolio managers are supported by the Scientific Advisory Board and their global networks, has enabled the fund to reach a high absolute level of returns since its inception in 2009.
Our investment team consists of portfolio managers who are responsible for different parts of the sector. The sub-sectors, pharmaceuticals, biotech, medical technology and healthcare services, all have different characteristics and drivers. The high level of innovation and complexity in the sector requires in-depth analysis.
Dynamic portfolio construction
Our portfolio construction is an important component in our model to reach a level of balance between risk and return in the fund. Our diversified portfolio consists of around 100-140 stocks, where several individual investments are less than 1 percent of the total portfolio. This method enables us to pressure-test newer, high potential companies early on in their journey and allow the position to grow gradually within the portfolio. Companies can also be removed without any major impact on the portfolio as a whole.
The fund has a global investment universe. The majority of the positions are, however, in the US where most of the healthcare industry is based.
In the last six years, over 40 companies in our portfolio have been acquired. This has resulted in a positive development for the fund’s initial investments and clearly demonstrates that our working method successfully identifies innovative companies at an early stage.
Fund management
The fund is managed by FundRock Management Company SA., who have commissioned Rhenman & Partners Asset Management to manage the fund’s portfolio.
Rhenman & Partners is authorized to conduct securities operations in the form of discretionary portfolio management regarding financial instruments. This means that Rhenman & Partners manages the fund’s portfolio, i.e. buys and sells securities within the framework of the fund’s investment regulations. However, we do not provide investment advice. Investors who are considering investing in the fund are strongly recommended to discuss investment questions with a professional investment advisor. For more information regarding the fund’s legal structure, please refer to the prospectus and the fund fact sheets.
